Literature DB >> 29998766

Selection of surgical intervention for congenital dacryocystocele.

Yi Zhang1, Yu Fan2, Jinlu Fan3, Yanhui Cui4.   

Abstract

PURPOSE: : To evaluate the surgical intervention and its effect on congenital dacryocystocele.
METHODS: : A total of 531 children with congenital dacryocystocele admitted to the Department of Ophthalmology of Beijing Children's Hospital, Shanghai Aier Eye Hospital, Nanjing Aier Eye Hospital, and the First Affiliated Hospital of Jinzhou Medical University between January 2007 and January 2017 were retrospectively analyzed.
RESULTS: : A total of 531 patients were followed up for 3-24 months, with an average of 13.3 months. No serious intraoperative complications (such as bleeding and tissue damage) and postoperative complications (bleeding, infection, and hole atresia) were found. We classified the outcomes into three categories based on the signs (overflowing tears and empyema) and objective routine follow-up by endoscopy. Cure indicated that mass, overflow of tears, and breathing difficulties disappeared, and 81.5% cases (433/531) were postoperatively cured. Improvement indicated disappearance of mass, overflow empyema, and the presence of residual tears (due to trocar and tears puncture), and 18.5% cases (98/531) were postoperatively improved. Unhealed indicated overflowing pus and tears, and 0% cases did not heal after surgery.
CONCLUSIONS: : Nasal endoscopic surgery is relatively safe, with high success rate for treatment of congenital dacryocystocele. Systematic training is required to promote the application of nasal endoscopy, so that more ophthalmologists can learn this technique.

Entities:  

Keywords:  Congenital dacryocystocele; nasal endoscopy; surgery

Mesh:

Year:  2018        PMID: 29998766     DOI: 10.1177/1120672118785276

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  3 in total

Review 1.  Neonatal nasal obstruction.

Authors:  Andrés Alvo; Galia Villarroel; Cecilia Sedano
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-03       Impact factor: 2.503

2.  Cost comparison of different treatment approaches of dacryocystitis and dacrocystocele.

Authors:  Erin G Sieck; Leonid Zukin; Jennifer L Patnaik; Anne M Lynch; Peggy Kelley; Jasleen K Singh
Journal:  Ther Adv Ophthalmol       Date:  2020-10-09

3.  Outcomes of lacrimal probing surgery as the first option in the treatment of congenital dacryocystocele.

Authors:  Cetin Akpolat; Selam Yekta Sendul; Ebru Turkoglu Unal; Egemen Karatas; Cemile Ucgul Atilgan; Mehmet Demir
Journal:  Ther Adv Ophthalmol       Date:  2021-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.